Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Mach7 Technologies ( (AU:M7T) ) just unveiled an announcement.
Mach7 Technologies Limited has announced a daily update on its ongoing on-market buy-back program, revealing that a total of 82,000 ordinary fully paid securities were bought back on the previous day, adding to the cumulative total of 5,138,000 securities repurchased. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares outstanding.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing innovative software solutions for the healthcare sector. The company specializes in developing enterprise imaging platforms that facilitate the management, storage, and sharing of medical images and data, aiming to enhance clinical workflows and improve patient care.
YTD Price Performance: -12.50%
Average Trading Volume: 248,300
Technical Sentiment Signal: Sell
Current Market Cap: A$84.43M
Learn more about M7T stock on TipRanks’ Stock Analysis page.